MYC and pancreatic neoplasm: Importantly, integrin inactivation-based proteasomal degradation was shown to be applicable to another MYC family oncoprotein, c-myc, which is over-expressed in a variety of malignant tumors, such as small cell lung cancer and pancreatic cancer.